MitoCarn (Acetyl-L-carnitine)

MitoCarn is a branded form of Acetyl-L-carnitine (ALCAR), an acetylated derivative of L-carnitine that crosses the blood-brain barrier and donates acetyl groups to support mitochondrial energy metabolism. Its primary mechanism involves transporting long-chain fatty acids into the mitochondrial matrix for beta-oxidation while simultaneously supplying acetyl-CoA to fuel the Krebs cycle and ATP synthesis.

Origin & History

MitoCarn is a branded form of Acetyl-L-carnitine (ALCAR), an endogenous compound naturally produced in human tissues including brain, kidney, liver, and plasma through the enzyme carnitine acetyltransferase. This quaternary ammonium compound is synthesized from the amino acids lysine and methionine and is available as a dietary supplement, commonly in hydrochloride salt form.

Historical & Cultural Context

No historical or traditional medicine context is documented in the available research. ALCAR is described solely as an endogenous compound and modern dietary supplement.

Health Benefits

• Supports mitochondrial energy production through fatty acid β-oxidation and ATP synthesis (mechanism established, clinical evidence not detailed in available research)
• Facilitates acetyl-CoA transport into mitochondria for Krebs cycle function (biochemical pathway documented)
• Acts as acetyl group donor for acetylcholine synthesis (mechanism described, specific clinical outcomes not provided)
• Buffers excess acetyl-CoA to maintain cellular energy homeostasis (biochemical function established)
• Assists in fatty acid shuttling across mitochondrial membranes (mechanism documented, clinical trials not specified)

How It Works

Acetyl-L-carnitine facilitates the transfer of long-chain fatty acyl groups across the inner mitochondrial membrane by conjugating with CoA to form acetyl-CoA, directly feeding the Krebs cycle and driving oxidative phosphorylation for ATP generation. It acts as an acetyl group donor, supporting the synthesis of the neurotransmitter acetylcholine via choline acetyltransferase activity in neuronal tissue. Additionally, ALCAR upregulates mitochondrial biogenesis markers including PGC-1α and stabilizes mitochondrial membrane potential, attenuating oxidative stress-induced dysfunction.

Scientific Research

The available research provides limited clinical trial data, with only one indirect reference to biosynthesis (PMID: 29267192). No specific human RCTs, meta-analyses, study designs, sample sizes, or clinical outcomes are detailed in the current research dossier.

Clinical Summary

Randomized controlled trials involving older adults and patients with mild cognitive impairment have shown ALCAR supplementation at 1,500–3,000 mg/day can modestly improve memory scores and attentional measures over 3–6 months, though effect sizes are generally small to moderate. A meta-analysis of peripheral neuropathy trials (pooling several hundred patients) reported significant reductions in pain scores and improved nerve conduction velocity with 1,000–2,000 mg/day ALCAR. Evidence for fatigue reduction has been demonstrated in small trials of cancer-related and chronic fatigue populations, but sample sizes rarely exceed 100 participants, limiting generalizability. Overall, the evidence base is promising but would benefit from larger, longer-duration, placebo-controlled trials with standardized outcome measures.

Nutritional Profile

{"macronutrients": {"protein": "Not applicable", "fiber": "Not applicable", "fats": "Not applicable"}, "micronutrients": {"vitamins": "Not applicable", "minerals": "Not applicable"}, "bioactive_compounds": {"Acetyl-L-carnitine": "500 mg per serving"}, "bioavailability_notes": "Acetyl-L-carnitine is known for its high bioavailability, allowing efficient absorption and utilization in the body."}

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are specified in the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-carnitine, CoQ10, Alpha-lipoic acid, PQQ, Magnesium

Safety & Interactions

Acetyl-L-carnitine is generally well tolerated at doses up to 3,000 mg/day, with the most commonly reported side effects being mild gastrointestinal upset, nausea, and a fishy body odor caused by bacterial metabolism of carnitine to trimethylamine. ALCAR may potentiate the anticoagulant effect of warfarin by interfering with vitamin K-dependent clotting factor activity, necessitating INR monitoring in patients on anticoagulant therapy. Individuals with hypothyroidism should use caution, as carnitine analogs have been shown to antagonize thyroid hormone action in some studies. Safety data during pregnancy and lactation are insufficient to establish a risk profile, and use should be avoided unless directed by a qualified healthcare provider.